Patent details

EP1471884 Title: PHARMACEUTICAL FORMULATION COMPRISING AN ANDROSTANE DERIVATIVE AND A SOLUBILISING AGENT IN AN AQUEOUS LIQUID CARRIER

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP1471884
WO Application Number:
GB2003000469
Type:
European Patent Granted for NL
Status:
Deemed not to be granted according to art. 52.4a or 52.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP03702727.3
WO Publication Number:
WO2003066026
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United Kingdom (GB)
Publications:

Dates

Filing date:
04/02/2003
Grant date:
18/10/2017
EP Publication Date:
03/11/2004
WO Publication Date:
14/08/2003
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
18/10/2017
EP B1 Publication Date:
18/10/2017
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
03/02/2023
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
18/10/2017
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
18/10/2017
 
 

 

Name:
Glaxo Group Limited
Address:
980 Great West Road, BRENTFORD, MIDDLESEX TW8 9GS, United Kingdom (GB)

Inventor

1

Name:
BIGGADIKE, Keith, GlaxoSmithKline
Address:
Stevenage, Hertfordshire SG1 2NY, United Kingdom (GB)

2

Name:
BUXTON, Ian, GlaxoSmithKline Inc.
Address:
Mississauga, Ontario L5N 6L4, Canada (CA)

3

Name:
DALEY-YATES, Peter, Terence, GlaxoSmithKline
Address:
Greenford, Middlesex UB6 0HE, United Kingdom (GB)

4

Name:
FONG, Bettina, GlaxoSmithKline Inc.
Address:
Mississauga, Ontario L5N 6L4, Canada (CA)

5

Name:
HO, Elita, Y., GlaxoSmithKline Inc.
Address:
Mississauga, Ontario L5N 6L4, Canada (CA)

6

Name:
REED, Kenton, Lewis, GlaxoSmithKline Inc.
Address:
Mississauga, Ontario L5N 6L4, Canada (CA)

7

Name:
SAYANI, Amyn, GlaxoSmithKline Inc.
Address:
Mississauga, Ontario L5N 6L4, Canada (CA)

Priority

Priority Patent Number:
66951
Priority Date:
04/02/2002
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 9/00; A61K 31/56; A61K 31/58; A61K 45/06; A61K 47/24; A61K 47/26; A61K 47/32; A61P 11/00; A61P 11/02; A61K 47/10; A61K 47/34; A61K 47/44;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
09/18
Publication date:
21/02/2018
Description:
Lapse or annulment

2

Bulletin Heading:
EP2
Journal edition number:
42/17
Publication date:
18/10/2017
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201742
Publication date:
18/10/2017
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type